Immunology drug pipeline

Immune-mediated disease therapeutics — rheumatoid arthritis, psoriasis, IBD, lupus, atopic dermatitis.

Recent approvals (last 30 days)

No approvals in this window.

Upcoming PDUFA dates (next 6 months)

No upcoming decisions in this window.

Top sponsors

1. GlaxoSmithKline · 238 drugs
2. · 140 drugs
3. Pfizer · 122 drugs
4. Sanofi Pasteur, a Sanofi Company · 89 drugs
5. Merck Sharp & Dohme LLC · 64 drugs
6. Sanofi · 59 drugs
7. Hoffmann-La Roche · 36 drugs
8. Novartis · 34 drugs
9. Sinovac Biotech Co., Ltd · 33 drugs
10. Amgen · 32 drugs

Key drug classes

• vaccine · 154
• Corticosteroid · 107
• Live attenuated vaccine · 105
• Calcineurin inhibitor · 78
• Inactivated influenza vaccine · 71
• Inactivated viral vaccine · 66
• Vaccine · 65
• Combination vaccine · 56
• Conjugate vaccine · 55
• Corticosteroid (glucocorticoid) · 49
• Nonsteroidal anti-inflammatory drug (NSAID) · 40
• mRNA vaccine · 39
• TNF-alpha inhibitor · 35
• Recombinant protein vaccine · 28
• TNF-α inhibitor (monoclonal antibody) · 27

Major diseases in this area

• rheumatoid arthritis
• psoriasis
• crohns disease
• ulcerative colitis

Subscribe

Get immunology approvals + PDUFA dates in your RSS reader:

• Immunology RSS feed · Atom · JSON

Other therapeutic areas